Changmao Biochemical Engineering Company Limited (0954.HK)
HKD 0.31
(1.67%)
HKD 0.31
(1.67%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 637.07 Million CNY | -12.73% |
| 2022 | 730.03 Million CNY | 33.22% |
| 2021 | 547.97 Million CNY | 23.39% |
| 2020 | 444.1 Million CNY | -10.21% |
| 2019 | 494.58 Million CNY | -22.62% |
| 2018 | 639.12 Million CNY | 1.31% |
| 2017 | 630.84 Million CNY | 6.13% |
| 2016 | 594.4 Million CNY | 15.47% |
| 2015 | 514.77 Million CNY | -8.35% |
| 2014 | 561.66 Million CNY | -20.11% |
| 2013 | 703.03 Million CNY | 7.63% |
| 2012 | 653.21 Million CNY | 5.32% |
| 2011 | 620.23 Million CNY | 20.3% |
| 2010 | 515.57 Million CNY | 33.81% |
| 2009 | 385.3 Million CNY | -7.92% |
| 2008 | 418.42 Million CNY | 5.29% |
| 2007 | 397.42 Million CNY | 23.64% |
| 2006 | 321.44 Million CNY | 245.48% |
| 2005 | 93.04 Million CNY | -2.3% |
| 2004 | 95.22 Million CNY | 6.61% |
| 2003 | 89.32 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 156.9 Million CNY | 0.0% |
| 2024 Q1 | 156.9 Million CNY | -7.83% |
| 2023 Q4 | 170.23 Million CNY | 0.0% |
| 2023 FY | 637.07 Million CNY | -12.73% |
| 2023 Q1 | 148.3 Million CNY | -14.58% |
| 2023 Q2 | 148.3 Million CNY | 0.0% |
| 2023 Q3 | 170.23 Million CNY | 14.79% |
| 2022 FY | 730.03 Million CNY | 33.22% |
| 2022 Q3 | 173.61 Million CNY | -9.3% |
| 2022 Q4 | 173.61 Million CNY | 0.0% |
| 2022 Q1 | 191.4 Million CNY | 26.92% |
| 2022 Q2 | 191.4 Million CNY | 0.0% |
| 2021 Q4 | 150.81 Million CNY | 0.0% |
| 2021 Q1 | 123.17 Million CNY | 9.9% |
| 2021 Q2 | 123.17 Million CNY | 0.0% |
| 2021 Q3 | 150.81 Million CNY | 22.43% |
| 2021 FY | 547.97 Million CNY | 23.39% |
| 2020 Q3 | 112.07 Million CNY | 1.92% |
| 2020 Q4 | 112.07 Million CNY | 0.0% |
| 2020 Q1 | 109.97 Million CNY | 11.82% |
| 2020 FY | 444.1 Million CNY | -10.21% |
| 2020 Q2 | 109.97 Million CNY | 0.0% |
| 2019 Q4 | 98.34 Million CNY | 0.0% |
| 2019 Q2 | 148.94 Million CNY | 0.0% |
| 2019 Q1 | 148.94 Million CNY | -7.43% |
| 2019 Q3 | 98.34 Million CNY | -33.97% |
| 2019 FY | 494.58 Million CNY | -22.62% |
| 2018 Q2 | 158.65 Million CNY | 0.0% |
| 2018 FY | 639.12 Million CNY | 1.31% |
| 2018 Q4 | 160.9 Million CNY | 0.0% |
| 2018 Q3 | 160.9 Million CNY | 1.42% |
| 2018 Q1 | 158.65 Million CNY | 2.72% |
| 2017 Q2 | 160.96 Million CNY | 0.0% |
| 2017 FY | 630.84 Million CNY | 6.13% |
| 2017 Q4 | 154.45 Million CNY | 0.0% |
| 2017 Q3 | 154.45 Million CNY | -4.05% |
| 2017 Q1 | 160.96 Million CNY | 8.24% |
| 2016 Q4 | 148.71 Million CNY | 0.0% |
| 2016 Q2 | 148.48 Million CNY | 0.0% |
| 2016 Q3 | 148.71 Million CNY | 0.15% |
| 2016 Q1 | 148.48 Million CNY | 20.06% |
| 2016 FY | 594.4 Million CNY | 15.47% |
| 2015 FY | 514.77 Million CNY | -8.35% |
| 2015 Q3 | 123.68 Million CNY | -7.5% |
| 2015 Q4 | 123.68 Million CNY | 0.0% |
| 2015 Q1 | 133.7 Million CNY | 4.46% |
| 2015 Q2 | 133.7 Million CNY | 0.0% |
| 2014 Q2 | 152.83 Million CNY | 0.0% |
| 2014 Q1 | 152.83 Million CNY | -11.21% |
| 2014 FY | 561.66 Million CNY | -20.11% |
| 2014 Q4 | 127.99 Million CNY | 0.0% |
| 2014 Q3 | 127.99 Million CNY | -16.25% |
| 2013 Q2 | 179.79 Million CNY | 0.46% |
| 2013 FY | 703.03 Million CNY | 7.63% |
| 2013 Q4 | 172.13 Million CNY | 0.0% |
| 2013 Q3 | 172.13 Million CNY | -4.26% |
| 2013 Q1 | 178.97 Million CNY | 6.71% |
| 2012 Q3 | 171.04 Million CNY | 10.37% |
| 2012 FY | 653.21 Million CNY | 5.32% |
| 2012 Q4 | 167.71 Million CNY | -1.95% |
| 2012 Q2 | 154.96 Million CNY | -2.84% |
| 2012 Q1 | 159.49 Million CNY | 2.19% |
| 2011 FY | 620.23 Million CNY | 20.3% |
| 2011 Q3 | 160.28 Million CNY | -0.86% |
| 2011 Q1 | 142.2 Million CNY | -10.22% |
| 2011 Q2 | 161.67 Million CNY | 13.69% |
| 2011 Q4 | 156.07 Million CNY | -2.63% |
| 2010 Q3 | 137.23 Million CNY | 9.56% |
| 2010 Q4 | 158.38 Million CNY | 15.42% |
| 2010 FY | 515.57 Million CNY | 33.81% |
| 2010 Q2 | 125.25 Million CNY | 0.0% |
| 2009 FY | 385.3 Million CNY | -7.92% |
| 2009 Q2 | 113.51 Million CNY | 0.0% |
| 2008 FY | 418.42 Million CNY | 5.29% |
| 2007 FY | 397.42 Million CNY | 23.64% |
| 2006 FY | 321.44 Million CNY | 245.48% |
| 2005 FY | 93.04 Million CNY | -2.3% |
| 2004 FY | 95.22 Million CNY | 6.61% |
| 2003 FY | 89.32 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Wai Chun Bio-Technology Limited | 773.65 Million HKD | 17.653% |
| Lee & Man Chemical Company Limited | 4.05 Billion HKD | 84.272% |